AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06233812 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Simple interrupted suturing technique
Description: Both simple interrupted and running epidermal sutures are considered acceptable, appropriate techniques for FTSG placement. Therefore, this study would be important in determining whether running sutures, the more efficient method, are non-inferior to simple interrupted sutures.
Study NCT06233812 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Running suturing technique
Description: Both simple interrupted and running epidermal sutures are considered acceptable, appropriate techniques for FTSG placement. Therefore, this study would be important in determining whether running sutures, the more efficient method, are non-inferior to simple interrupted sutures.
Study NCT05379491 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3 L PEG + linaclotide
Description: Participants take a linaclotide capsule on the day before colonoscopy at least 30 minutes before the first meal (if this is impossible, take the capsule as early as possible on that day). Participants take 1 L polyethylene glycol electrolyte solution within 1 hour from 8 p.m the night before the examination and take another linaclotide capsule and 2 L polyethylene glycol electrolyte solution 4 hours before the colonoscopy.
Study NCT05379491 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 3 L PEG + placebo
Description: Participants take a placebo capsule on the day before colonoscopy at least 30 minutes before the first meal (if this is impossible, take the capsule as early as possible on that day). Participants take 1 L polyethylene glycol electrolyte solution within 1 hour from 8 p.m the night before the examination and take another placebo capsule and 2 L polyethylene glycol electrolyte solution 4 hours before the colonoscopy.
Study NCT06269822 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Sympathetic skin response, heart rate variability test, quantitative EEG
Description: Sympathetic skin test (electrodermal activity) to test for sympathetic function Heart rate variability test to assess cardiovagal function Quantitative EEG to quantitatively assessing the brain function using fast fourier transform technique
Study NCT05603338 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LSG with omental band
Description: LSG with omental band
Study NCT05603338 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LSG
Description: just to do sleeve gastrectomy
Study NCT05925686 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol.
Description: Orally single dose administration of Tramadol 75 mg for ultra-rapid metabolizers and 100 mg for extensive and poor metabolizers.
Study NCT06184854 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D-Enhanced Training Models
Description: 3D-enhanced Jenga polo model for task 1 and 3D-enhanced suturing model for task 2
Study NCT06184854 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard 3D LapPass Training Models
Description: Standard 3D LapPass polo model for task 1 and standard 3D LapPass model for task 2
Study NCT06071624 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD4CAR
Description: CD4CAR cells transduced with a lentiviral vector to express the single-chain variable fragment (scFv) nucleotide sequence of the anti-CD4 molecule derived from humanized monoclonal ibalizumab and the intracellular domains of CD28 and 4-1BB co-activators fused to the CD3ζ T-cell activation signaling domain administered by IV infusions as a single dose
Study NCT06343103 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Workers exposed
Description: Workers exposed to cytotoxic agents
Study NCT06343103 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Workers not exposed
Description: Workers not exposed to cytotoxic agents
Study NCT05093218 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: branch chain amino acid
Description: • Branch chain amino acid at a dose of approxiametely 0.35g/kg will be supplemented in two divided doses group for a period of 12 weeks.For the sake of administration, it will be prescribed as per the following weight band categories: \<5kg 2 gm 5-10kg 4 gm 10-20kg 8 gm 20-40kg 12 gm 40-60kg 24 gm
Study NCT05093218 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo will have the similar colour, taste and consistency. Both groups will be given the same dose.
Study NCT04497727 — intervention group
Intervention type: OTHER
Intervention: Gene Expression
Description: Gene expression analysis of biopsy specimens obtained during routine colonoscopy examination
Study NCT04702724 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Targeted memory reactivation (sounds)
Description: I will unobtrusively and repeatedly present learning-related sounds during sleep using speakers. This method was shown to improve memory in various tasks. The sounds will be presented several seconds apart and the volume will be so adjusted as not to disturb the participant's sleep. The sounds will be presented during non-rapid eye movement sleep (sleep stage 2 and slow wave sleep). The sounds presented will be congruently related to the images in the previous learning task. This manipulation is within-subject - all participants will get it, but different specific sounds will be presented for each individual participant.
Study NCT04798391 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Steroids and analgesics
Study NCT05210452 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Follicular stem cells
Description: Cultured autologous follicular stem cells
Study NCT05210452 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment according to the clinical protocols
Description: Standard treatment of alopecia according to the clinical protocols
Study NCT05210452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard treatment according to the clinical protocols
Description: Standard treatment of alopecia according to the clinical protocols
Study NCT05426057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eHealth Familias Unidas Mental Health
Description: eHealth Familias Unidas is a program designed to target mental health and suicide ideation and behavior. It focuses on promoting mental health by strengthening family and interpersonal protective factors. The program is provided online over a total of 13 sessions: 9 video parent group sessions, each lasting 20-40 minutes in Spanish and 4 web family sessions lasting 45 minutes in either Spanish or English, depending on participant language preference. The video parent group sessions consist of: 1) culturally syntonic telenovela/soap opera series, 2) videotaped parent group discussions, 3) interactive exercises. Web family sessions will be conducted by a trained pediatric staff member.
Study NCT06160414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Participants will receive Metformin orally, after fasting.
Study NCT06160414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Participants will receive Rosuvastatin orally, after fasting.
Study NCT06160414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN2080
Description: Participants will receive ALXN2080 orally, after fasting.
Study NCT06355479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OsrHSA
Description: Recombinant Human Serum Albumin from Oryza Sativa
Study NCT06355479 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Plasbumin®-20
Description: Albumin (Human) 20%, USP
Study NCT05715476 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cesarian surgery
Description: The same anesthesia protocol will be applied to the patient group at each altitude. In the sitting position, the spinal space was entered with a 25 gauge Quincke-tipped needle from the L4-5 space and a drop of CSF will be dripped onto the pH paper. Immediately afterwards, 12 mg of 0.5% hyperbaric bupivacaine will be given. The color formed on the pH paper will be noted. Sensory block level will be tested with pinprick test and motor block level will be evaluated with Modified Bromage scale. The number and duration of spinal anesthesia applications, the time of occurrence of sensory block in the T6 dermatome, the time to reach each score of the MB scale, the duration of the operation, the highest level of sensory block and anesthetic complications will be recorded. Sensory block time and motor block time of the patients followed in the service will be recorded.
Study NCT06212050 — intervention group
Intervention type: DEVICE
Intervention: Transcatheter Aortic Valve Implantation
Description: TAVI in patients with severe BAV stenosis using ACURATE neo2
Study NCT06447324 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fender Mate matrix system
Description: Matrix Systems used for Restoration of Class II Cavities in Primary Molars
Study NCT06447324 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: T-band matrix
Description: Matrix Systems used for Restoration of Class II Cavities in Primary Molars
Study NCT06228950 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction
Description: A therapeutic approach called mindfulness-based stress reduction, or MBSR, aims to reduce emotional and behavioral problems by fostering mindfulness, which is an impartial awareness of the present moment. MBSR will be an 8-week training course for students with visual impairment. MBSR training, translated and adapted in Urdu language that includes 8 audios and worksheets corresponding to each week. Worksheets to record home practice will be filled upon receiving oral feedback from the students with visual impairment. Face-to-face group-based sessions will be conducted weekly.
Study NCT06113861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Quantiferon Gold
Description: Test for TB infection
Study NCT06113861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: HIV serology
Description: Test for HIV infection
Study NCT06179615 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: surface hardness test for denture teeth
Description: surface hardness test of denture teeth at insertion then after 6 months of use
Study NCT06179615 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: wear resistance of denture teeth measurement
Description: 2D, Vertical wear, 3D Volumetric wear were measured for denture teeth
Study NCT06145685 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimally invasive non-surgical periodontal therapy
Description: Minimally invasive non-surgical periodontal therapy
Study NCT06145685 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional non-surgical periodontal therapy
Description: Conventional non-surgical periodontal therapy
Study NCT05596630 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy
Description: Stereotactic body radiotherapy for small intrahepatic recurrent HCC. Radiation dose: Greater than or equal to 40Gy/4-5F, complete treatment within 1 week.
Study NCT05674045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EG017 3mg
Description: EG017 3mg/day Oral administration for 12 weeks, once daily
Study NCT05674045 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: EG017 3mg
Description: EG017 3mg/day Oral administration for 12 weeks, once daily
Study NCT05674045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EG017 6mg
Description: EG017 6mg/day Oral administration for 12 weeks, once daily
Study NCT05674045 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: EG017 6mg
Description: EG017 6mg/day Oral administration for 12 weeks, once daily
Study NCT05658185 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MIDITRA
Description: The psychological treatment protocol will be implemented over 10 group sessions of face-to-face psychological treatment with patients. The treatment sessions will have the following objectives and themes:~* Adjustment to the disease:~* Self-esteem/self-concept:~* Coping with fear:~* Emotional self-regulation:~* Social area and enjoyment:~* Decision making and problem solving:~* Communication and listening skills:
Study NCT06467253 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 1. rTMS + CS
Description: In the first phase each participant will receive 15 sessions of rTMS and 9 sessions of CS divided in 3 weeks, in the maintenance phase each participant will receive 1 session of rTMS and 1 session of CS per week for 12 weeks. Each session will consist of 10 trains of 10 stimuli, at a 5-Hz frequency and a stimulation intensity of 120% of the resting motor threshold.~rTMS will be administered by a MagPro R30 stimulator (MagVenture) and an active/placebo 8-shape coil model MCF-B70.~Two surface electrodes will be employed to replicate rTMS skin sensations near the stimulation site. The rTMS condition will be double-blinded through the use of a USB stick.~Cognitive stimulation will be a Mexican adaptation of the Memory Training and Cognitive Stimulation for Mild Cognitive Impairment from the Center for the Prevention of Cognitive Impairment of the Madrid City Council.~In total, each participant will receive 27 sessions of rTMS and 21 sessions of CS.
Study NCT06467253 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: 2. rTMS Sham + CS
Description: In the first phase each participant will receive 15 sessions of rTMS Sham and 9 sessions of CS divided in 3 weeks, in the maintenance phase each participant will receive 1 session of Sham rTMS and 1 session of CS per week for 12 weeks.~In total, each participant will receive 27 sessions of Sham rTMS and 21 sessions of CS.~rTMS will be administered by a MagPro R30 stimulator (MagVenture) and an active/placebo 8-shape coil model MCF-B70.~Two surface electrodes will be employed to replicate rTMS skin sensations near the stimulation site. The sham condition will be double-blinded through the use of a USB stick.~Cognitive stimulation will be a Mexican adaptation of the Memory Training and Cognitive Stimulation for Mild Cognitive Impairment from the Center for the Prevention of Cognitive Impairment of the Madrid City Council.~In total, each participant will receive 27 sessions of rTMS and 21 sessions of CS.
Study NCT06467253 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 3. tDCS + CS
Description: In the first phase each participant will receive 15 sessions of tDCS and 9 sessions of CS divided in 3 weeks, in the maintenance phase each participant will receive 1 session of tDCS and 1 session of CS per week for 12 weeks. Each session will consist of the delivery of a weak direct current of 2mA for 30 minutes.~tDCS will be administered by the Sooma tDCS stimulator. The tDCS condition will be double-blinded, and a third operator will program the stimulator.~Cognitive stimulation will be a Mexican adaptation of the Memory Training and Cognitive Stimulation for Mild Cognitive Impairment from the Center for the Prevention of Cognitive Impairment of the Madrid City Council.~In total, each participant will receive 27 sessions of tCDS and 21 sessions of CS.
Study NCT06113861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Respiratory secretion culture (sputum or gastric aspirate_
Description: TB culture by MODS
Study NCT06113861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Chest radiograph
Description: Chest imaging test by traditional X ray
Study NCT06467253 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: 4. tDCS Sham + CS
Description: In the first phase each participant will receive 15 sessions of tDCS Sham and 9 sessions of CS divided in 3 weeks, in the maintenance phase each participant will receive 1 session of Sham tDCS and 1 session of CS per week for 12 weeks.~tDCS will be administered by the Sooma tDCS stimulator. The sham condition will be double-blinded, and a third operator will program the stimulator.~Cognitive stimulation will be a Mexican adaptation of the Memory Training and Cognitive Stimulation for Mild Cognitive Impairment from the Center for the Prevention of Cognitive Impairment of the Madrid City Council.~In total, each participant will receive 27 sessions of Sham tDCS and 21 sessions of CS.
Study NCT05204615 — intervention group
Intervention type: OTHER
Intervention: Collection of clinical, psychometric and biometric data
Description: Wearable devices and a mobile app will be used to collect real-time data for 4 weeks to detect physiological and psychological complications based on biometric and psychometric (patient-reported outcomes) information.
Study NCT06469684 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Health education session
Description: 1 hour health education session religious teaching promoting health-seeking behaviour, and question and answer session with healthcare professional.
Study NCT05241418 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Atrial 3D late gadolinium enhancement
Description: We will use cardiac MRI to take a picture of the atria. This picture will be used to identify scar tissue within the atria.
Study NCT05603455 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium adolescentis
Description: Supplement with Bifidobacterium adolescentis twice/day in morning and tonight for 6 months
Study NCT05603455 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05595642 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Astegolimab
Description: Participants will receive SC astegolimab Q2W or Q4W
Study NCT05595642 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive SC placebo Q2W
Study NCT06567743 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cretostimogene Grenadenorepvec
Description: Cohort A, Arm 1 and 2
Study NCT06567743 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: n-dodecyl-B-D-maltoside
Description: Transduction-enhancing agent
Study NCT04881734 — intervention group
Intervention type: OTHER
Intervention: Overtime pancreaticoduodenectomy
Description: Compared with daytime surgery, the intervention in this study is to work overtime after 17:00 to perform pancreaticoduodenectomy.
Study NCT05232422 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hatha yoga course
Description: Participants will join a free hatha yoga course, conducted by a professional yoga teacher, over a time period of eight weeks with a frequency of at least three up to five times a week. The quality of the implementation of the intervention will be checked through post-monitoring by short questionnaires to be filled out by participants.
Study NCT06113861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lung ultrasound
Description: Chest imaging test by ultrasound
Study NCT06113861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: cell free DNA test
Description: Blood test for TB infection
Study NCT06489002 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Implementation Support
Description: Health centers receiving the intervention will have access to implementation support strategies designed to support adoption of social needs screenings and referrals to community organizations for patients with unmet social needs receiving care management. Implementation support will be provided by an OCHIN trainer, practice facilitators, workflow engineer, and analysts.
Study NCT06329219 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: water-filtered Infrared-A radiation
Description: The water-filtered Infrared-A radiation device is designed for self-administered home treatments. The regimen prescribes 30-minute sessions, five times weekly, spanning 12 weeks.
Study NCT06261099 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: control + working group
Description: Upper extremity positioning, overhead activity training, reaching activities, weight transfer exercises, proprioceptive exercises, and daily living activities training will be applied to this group using the telerehabilitation method, which was applied to in 5 sessions per week for 6 weeks.
Study NCT05126706 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital lifestyle management
Description: Digital lifestyle management for Weight Loss Control after Thyroidectomy
Study NCT04677621 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse Telehealth
Description: Subjects will receive nurse telehealth Mobile Decision Support System (MAP) DBS care
Study NCT04677621 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: STANDARD DBS
Description: Subjects will receive standard in-person clinic-based DBS care administered without the use of Mobile Decision Support System (MAP) DBS
Study NCT05135130 — intervention group
Intervention type: DRUG
Intervention: ON101 Cream
Description: Not applicable in this retrospective study
Study NCT06469684 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health education session
Description: 1 hour health education session religious teaching promoting health-seeking behaviour, and question and answer session with healthcare professional.
Study NCT05739903 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-1229_01 5/1000mg (Before)
Description: single dose administration (one tablet once a day)
Study NCT05739903 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-1229_01 5/1000mg (After)
Description: single dose administration (one tablet once a day)
Study NCT04876573 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyproheptadine Hydrochloride 4 MG
Description: Phase 1: Cyproheptadine 4 mg three time a day for 10 days, per oral administration associated to Standard care of COVID 19 patient currently recommend by WHO~Phase 2: Cyproheptadine 8 mg three time a day for 10 days, per oral administration associated to Standard care of COVID 19 patient currently recommend by WHO~The dose will be adjusted according to the renal function.